NASDAQ:BCAC

Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$9.94
$27.74
50-Day Range
$0.36
$22.71
52-Week Range
$9.50
$27.74
Volume
586,400 shs
Average Volume
39,682 shs
Market Capitalization
$153.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BCAC stock logo

About Brookline Capital Acquisition Stock (NASDAQ:BCAC)

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

BCAC Stock News Headlines

Q2 2023 electroCore, Inc. Earnings Call
The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
LFAC LF Capital Acquisition Corp. II
Apexigen Announces Board Appointment and New Chair
The asset beating inflation by 4x
"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.
Brookline Capital Acquisition Corp.
See More Headlines
Receive BCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BCAC
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-480,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
5,451,000
Market Cap
$153.20 million
Optionable
Not Optionable
Beta
-0.03
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Samuel P. Wertheimer Ph.D.
    Chairman & CEO
  • Mr. Scott A. Katzmann (Age 66)
    Pres & Director
  • Mr. Patrick Sturgeon
    Chief Financial Officer

This page (NASDAQ:BCAC) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners